Rapidon

Rapidon may be available in the countries listed below.

Ingredient matches for Rapidon

Paracetamol

Paracetamol is reported as an ingredient of Rapidon in the following countries:

• Bangladesh

International Drug Name Search

dimenhydrinate

Generic Name: dimenhydrinate (dye men HYE dri nate)

Brand names: Dramamine, Driminate, Hydrate, Dramoject, Dymenate, DMH, Triptone

What is dimenhydrinate?

Dimenhydrinate is used to prevent and treat nausea, vomiting, dizziness, and vertigo associated with motion sickness.

Dimenhydrinate may also be used for purposes other than those listed in this medication guide.

What is the most important information I should know about dimenhydrinate?

Use caution when driving, operating machinery, or performing other hazardous activities. Dimenhydrinate may cause dizziness, drowsiness, or blurred vision. If you experience dizziness, drowsiness, or blurred vision, avoid these activities. Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while you are taking dimenhydrinate.

Who should not take dimenhydrinate?

Before taking this medication, tell your doctor if you have

• 
  

  kidney or liver disease,

  
  


• 
  

  an enlarged prostate,

  
  


• 
  

  difficulty urinating,

  
  


• 
  

  bladder problems,

  
  


• 
  

  glaucoma,

  
  


• 
  

  asthma, or

  
  


• 
  

  an irregular heartbeat or any other type of heart disease.

  
  

You may not be able to take dimenhydrinate, or you may require a lower dose or special monitoring during treatment if you have any of the conditions listed above.

Dimenhydrinate is in the FDA pregnancy category B. This means that it is unlikely to harm an unborn baby. Do not take dimenhydrinate without first talking to your doctor if you are pregnant. Dimenhydrinate passes into breast milk and may harm a nursing baby. Do not take dimenhydrinate without first talking to your doctor if you are breast-feeding a baby. Dimenhydrinate is not recommended for use by children younger than 2 years of age, except under the direction of a doctor.

How should I take dimenhydrinate?

Take dimenhydrinate exactly as directed by your doctor. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.

Take each dose with a full glass of water.

To ensure that you get a correct dose, measure the liquid form of dimenhydrinate with a special dose-measuring spoon or cup, not with a regular tablespoon. If you do not have a dose-measuring device, ask your pharmacist where you can get one.

Dimenhydrinate is usually taken every 4 to 6 hours as needed. Do not take more than 400 mg of this medication in one day.

Store dimenhydrinate at room temperature away from moisture and heat.

See also: Dimenhydrinate dosage (in more detail)

What happens if I miss a dose?

Take the missed dose as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and take only your next regularly scheduled dose. Do not take a double dose of this medication.

What happens if I overdose?

Seek emergency medical attention.

Symptoms of a dimenhydrinate overdose include drowsiness, seizures or convulsions, difficulty breathing, and death.

What should I avoid while taking dimenhydrinate?

Use caution when driving, operating machinery, or performing other hazardous activities. Dimenhydrinate may cause dizziness, drowsiness, or blurred vision. If you experience dizziness, drowsiness, or blurred vision, avoid these activities. Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while you are taking dimenhydrinate.

Dimenhydrinate side effects

Stop taking dimenhydrinate and seek emergency medical attention if you experience an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives).

Other, less serious side effects may be more likely to occur. Continue to take dimenhydrinate and talk to your doctor if you experience

• 
  

  drowsiness or dizziness;

  
  


• 
  

  restlessness, excitation, nervousness, or insomnia;

  
  


• 
  

  blurred or double vision;

  
  


• 
  

  dry mouth, nose, or throat;

  
  


• 
  

  decreased appetite, nausea, vomiting, or diarrhea;

  
  


• 
  

  difficulty urinating; or

  
  


• 
  

  an irregular or fast heartbeat.

  
  

Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.

Dimenhydrinate Dosing Information

Usual Adult Dose for Motion Sickness:

50 to 100 mg, orally, IM or IV, every 4 to 6 hours, to a maximum of 400 mg in 24 hours. The first dose should be taken 30 to 60 minutes before starting activity.

Usual Pediatric Dose for Motion Sickness:

Greater than or equal to 2 to less than 6 years: 12.5 to 25 mg orally every 6 to 8 hours, to a maximum of 75 mg in 24 hours.

Greater than or equal to 6 to less than 12 years: 25 to 50 mg orally every 6 to 8 hours, to a maximum of 150 mg in 24 hours.

Greater than 12 years: 25 to 100 mg orally 30 to 60 minutes before starting activity, then 25 to 100 mg every 4 to 6 hours, to maximum of 400 mg in 24 hours.

The first dose should be taken 30 to 60 minutes before starting activity.

What other drugs will affect dimenhydrinate?

Dimenhydrinate may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, antihistamines, sedatives (used to treat insomnia), pain relievers, anxiety medicines, and muscle relaxants. Tell your doctor about all medicines that you are taking, and do not take any medicine unless your doctor approves.

Drugs other than those listed here may also interact with dimenhydrinate. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.

More dimenhydrinate resources

• Dimenhydrinate Side Effects (in more detail)
• Dimenhydrinate Dosage
• Dimenhydrinate Use in Pregnancy & Breastfeeding
• Drug Images
• Dimenhydrinate Drug Interactions
• Dimenhydrinate Support Group
• 12 Reviews for Dimenhydrinate - Add your own review/rating

• Dimenhydrinate Prescribing Information (FDA)


• Dimenhydrinate Professional Patient Advice (Wolters Kluwer)


• Dimenhydrinate Monograph (AHFS DI)


• Dimenhydrinate MedFacts Consumer Leaflet (Wolters Kluwer)


• Dramamine MedFacts Consumer Leaflet (Wolters Kluwer)

Compare dimenhydrinate with other medications

• Motion Sickness
• Nausea/Vomiting

Where can I get more information?

• Your pharmacist has more information about dimenhydrinate written for health professionals that you may read.

See also: dimenhydrinate side effects (in more detail)

Nirmin

Nirmin may be available in the countries listed below.

Ingredient matches for Nirmin

Nitroglycerin

Nitroglycerin is reported as an ingredient of Nirmin in the following countries:

• Serbia

International Drug Name Search

Sandoz Pyrazinamide

Sandoz Pyrazinamide may be available in the countries listed below.

Ingredient matches for Sandoz Pyrazinamide

Pyrazinamide

Pyrazinamide is reported as an ingredient of Sandoz Pyrazinamide in the following countries:

• South Africa

International Drug Name Search

Eutizon

Eutizon may be available in the countries listed below.

Ingredient matches for Eutizon

Pyridoxine

Pyridoxine is reported as an ingredient of Eutizon in the following countries:

• Croatia (Hrvatska)

International Drug Name Search

Lovachol

Lovachol may be available in the countries listed below.

Ingredient matches for Lovachol

Lovastatin

Lovastatin is reported as an ingredient of Lovachol in the following countries:

• South Africa

International Drug Name Search

Dipotassium Phosphate

Dipotassium Phosphate may be available in the countries listed below.

Ingredient matches for Dipotassium Phosphate

Potassium Phosphate

Potassium Phosphate, Dibasic is reported as an ingredient of Dipotassium Phosphate in the following countries:

• Japan

International Drug Name Search

Taka-Diastase

ATC (Anatomical Therapeutic Chemical Classification)

A09AA01

CAS registry number (Chemical Abstracts Service)

0009001-19-8

Therapeutic Categories

Enzyme

Drug acting on the digestive tract

Foreign Name

• Aspergillus oryzae carboxyl proteinase (German)

Generic Names

• Aspergillopepsin I (IS)
• Takadiastase (IS)
• Trypsinogen kinase (IS)

Brand Name

• Orenzym
  Noventis, Czech Republic

International Drug Name Search

Glossary

IS	Inofficial Synonym

Click for further information on drug naming conventions and International Nonproprietary Names.

Ramipril Tenlec

Ramipril Tenlec may be available in the countries listed below.

Ingredient matches for Ramipril Tenlec

Ramipril

Ramipril is reported as an ingredient of Ramipril Tenlec in the following countries:

• Netherlands

International Drug Name Search

Kefamin

Kefamin may be available in the countries listed below.

Ingredient matches for Kefamin

Ceftazidime

Ceftazidime pentahydrate (a derivative of Ceftazidime) is reported as an ingredient of Kefamin in the following countries:

• Spain

International Drug Name Search

Rifabutin Pfizer

Rifabutin Pfizer may be available in the countries listed below.

Ingredient matches for Rifabutin Pfizer

Rifabutin

Rifabutin is reported as an ingredient of Rifabutin Pfizer in the following countries:

• Denmark

International Drug Name Search

Leparson

Leparson may be available in the countries listed below.

Ingredient matches for Leparson

Benserazide

Benserazide hydrochloride (a derivative of Benserazide) is reported as an ingredient of Leparson in the following countries:

• Indonesia

Levodopa

Levodopa is reported as an ingredient of Leparson in the following countries:

• Indonesia

International Drug Name Search

Quinine

In the US, Quinine (quinine systemic) is a member of the drug class antimalarial quinolines and is used to treat Malaria and Nocturnal Leg Cramps.

US matches:

• Quinine


• Quinine Capsules


• Quinine Sulfate

UK matches:

• Quinine Sulphate Tablets 200mg
• Quinine Sulphate Tablets 300mg
• Quinine Bisulphate Tablets 300mg (SPC)

Scheme

BAN

ATC (Anatomical Therapeutic Chemical Classification)

M09AA,M09AA72,P01BC01

CAS registry number (Chemical Abstracts Service)

0000130-95-0

Chemical Formula

C20-H24-N2-O2

Molecular Weight

324

Therapeutic Categories

Antiprotozoal agent: Antimalarial

Antipyretic

Chemical Names

(R)-[(5R,7S)-5-ethenyl-1-azabicyclo[2.2.2]octan-7-yl]-(6-methoxyquinolin-4-yl)methanol (IUPAC)

Cinchonan-9-ol, 6'-methoxy-, (8α,9R)-

Foreign Names

• Chinin (German)
• Quinine (French)

Generic Names

• Quinine (OS: DCF, BAN)
• Chininum (IS)
• Chinina (PH: F.U. IX)
• Quinine Dihydrochloride (OS: BANM)
• Chininum dihydrochloricum (IS)
• Chininum dihydrochloricum (PH: ÖAB 2009)
• Quinine Dihydrochloride (PH: NF XIII, Ph. Int. 4, BP 2010)
• Quinini dihydrochloridum (PH: Ph. Int. 4)
• Quinine Ethylcarbonate (OS: JAN)
• Chininum aethylocarbonicum (IS)
• Euquinine (IS)
• Quinine Ethylcarbonate (PH: JP XIV)
• Quinine Hydrochloride (OS: BANM, JAN)
• Chininhydrochlorid (PH: Ph. Eur. 6)
• Chinini hydrochloridum (PH: Ph. Eur. 6)
• Quinine (chlorhydrate de) (PH: Ph. Eur. 6)
• Quinine Hydrochloride (PH: BP 2010, JP XIV, Ph. Int. 4, Ph. Eur. 6)
• Quinini hydrochloridum (PH: Ph. Int. 4)
• Quinine Bisulphate (OS: BANM)
• Chinina solfato (PH: F.U. IX)
• Quinine Bisulfate (PH: Ph. Int. 4)
• Quinine Bisulphate (PH: BP 2010)
• Quinini bisulfas (PH: Ph. Int. 4)
• Quinine Sulfate (OS: JAN)
• Quinine Sulphate (OS: BANM)
• Chininium sulfuricum (IS)
• Chinini sulfas (PH: Ph. Eur. 6)
• Chininsulfat (PH: Ph. Eur. 6)
• Quinine (sulfate de) (PH: Ph. Eur. 6)
• Quinine Sulfate (PH: Ph. Int. 4, USP 30, JP XIV)
• Quinine Sulphate (PH: Ph. Eur. 6, BP 2010)
• Quinini sulfas (PH: Ph. Int. 4)

Brand Names

• Hexaquine (Quinine and Thiamine)
  Gomenol, France



• Jasoquin
  Jayson, Bangladesh



• Quinine DiHCl.
  Pharmadrug, Germany



• Quinine Dihydrochloride
  Phebra, Australia



• Quinine
  Biomed, New Zealand



• Quininga
  Inga, India



• Aethylcarbonas Chinin
  Kimia Farma, Indonesia



• A.N.B. Quinine Dihydrochloride
  ANB, Myanmar



• Analgin-Chinin (Quinine and Metamizole)
  Sopharma, Russian Federation



• Chinina Cloridrato Galenica
  Galenica Senese, Italy



• Chinina Cloridrato Salf
  Salf, Italy



• Chininum hydrochloricum
  Mylan dura, Germany



• Kinin Recip
  Recip, Sweden



• Kinin SAD
  Amgros, Denmark



• Kinuréa H (Quinine and Urea)
  Neitum, France



• Quinimax
  Sanofi-Aventis, France; Sanofi-Synthelabo, Ghana; Sanofi-Synthelabo, Kenya; Sanofi-Synthelabo, Nigeria; Sanofi-Synthelabo, Tanzania; Sanofi-Synthelabo, Uganda



• Quinine Lafran
  Lafran, France



• Requin
  Rephco, Bangladesh



• Surquina
  Innotech, France



• Quinine Bisulphate
  Remedica, Cyprus



• Apo-Quinine
  Apotex, Canada



• Chinina Solfato Afom
  AFOM, Italy



• Chinina Solfato Nova Argentia
  Nova Argentia, Italy



• Chininsulfat Hänseler
  Hänseler, Switzerland



• Circonyl
  TRB, Argentina



• Kanaquine
  Globe, Bangladesh



• Kinin Actavis
  Actavis, Iceland



• Lennon-Quinine Sulphate
  Aspen Pharmacare, South Africa



• Limptar
  Cassella-med, Germany



• Malaten
  Masa Lab, Myanmar



• Q200
  Pacific, New Zealand



• Q300
  Pacific, New Zealand



• Qualaquin
  AR Scientific, United States



• Quinate
  Aspen, Australia



• Quinbisul
  Aspen, Australia



• Quinina
  Cipa, Peru



• Quinine Sulfate
  Actavis, Ireland; Rekah, Israel



• Quinine Sulphate
  Actavis, United Kingdom; CP, Malta; Remedica, Cyprus; Wockhardt, United Kingdom



• Quinine-H
  Hudson, Bangladesh



• Quinine-Odan
  Odan, Canada



• Quininga
  Inga, India



• Quinsul
  Lennon Healthcare, Australia

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Vinorelbine ActavisGroup

Vinorelbine ActavisGroup may be available in the countries listed below.

Ingredient matches for Vinorelbine ActavisGroup

Vinorelbine

Vinorelbine tartrate (a derivative of Vinorelbine) is reported as an ingredient of Vinorelbine ActavisGroup in the following countries:

• Netherlands

International Drug Name Search